Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
Recruiting now · Not applicable
Conditions studied: Malignant Solid Neoplasm
In brief
This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.
Key facts
- Study ID
- NCT06541158
- Run by
- Emory University
- People needed
- 76
- Starts
- 2024-11-06
- Expected to finish
- 2028-05-15
- Last updated by the study team
- 2026-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Diagnosed with solid tumors
- Undergoing RT (not excluded with chemotherapy)
- Competent to give consent
- English-speaking
- With travel barriers as screened by the reliable and validated 10-item Transportation Barriers Measure. In this study, item 2 ("how much trouble is it for you to get transportation to your doctor or treatment?") from the general barriers domain will be used to screen patients for travel barriers
You may not qualify if…
- Receive palliative care
- Are non-English-speaking (excluded due to pilot data without fund to support translation services)
- Are enrolled in lodging programs (e.g., the American Cancer Society [ACS] Hope Lodge®)
- Have major depression/anxiety disorders that interfere with their ability to participate (based on the electronic medical records report)
Where it is running
- Emory University Hospital Midtown — Atlanta, Georgia, United States (enrolling)
- Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States (enrolling)
- Emory Saint Joseph's Hospital — Atlanta, Georgia, United States (enrolling)
- Emory Proton Therapy Center — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.